ACET
Price
$0.71
Change
-$0.01 (-1.39%)
Updated
Apr 3, 02:23 PM (EDT)
Capitalization
59.86M
47 days until earnings call
DVAX
Price
$12.87
Change
-$0.01 (-0.08%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
1.62B
28 days until earnings call
Ad is loading...

ACET vs DVAX

Header iconACET vs DVAX Comparison
Open Charts ACET vs DVAXBanner chart's image
Adicet Bio
Price$0.71
Change-$0.01 (-1.39%)
Volume$300
Capitalization59.86M
Dynavax Technologies
Price$12.87
Change-$0.01 (-0.08%)
Volume$60.26K
Capitalization1.62B
ACET vs DVAX Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. DVAX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and DVAX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ACET: $0.72 vs. DVAX: $12.87)
Brand notoriety: ACET and DVAX are both not notable
ACET represents the Biotechnology, while DVAX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 47% vs. DVAX: 74%
Market capitalization -- ACET: $59.86M vs. DVAX: $1.62B
ACET [@Biotechnology] is valued at $59.86M. DVAX’s [@Pharmaceuticals: Other] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileDVAX’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • DVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 2 TA indicator(s) are bullish while DVAX’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 2 bullish, 7 bearish.
  • DVAX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -19.22% price change this week, while DVAX (@Pharmaceuticals: Other) price change was -5.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.22%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.34%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.00%. For the same industry, the average monthly price growth was +65.26%, and the average quarterly price growth was -10.39%.

Reported Earning Dates

ACET is expected to report earnings on May 20, 2025.

DVAX is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-8.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (-3.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than ACET($59.9M). DVAX YTD gains are higher at: 0.783 vs. ACET (-24.740). DVAX has higher annual earnings (EBITDA): 9.67M vs. ACET (-110.65M). DVAX has more cash in the bank: 742M vs. ACET (176M). ACET has less debt than DVAX: ACET (17.2M) vs DVAX (257M). DVAX has higher revenues than ACET: DVAX (232M) vs ACET (0).
ACETDVAXACET / DVAX
Capitalization59.9M1.62B4%
EBITDA-110.65M9.67M-1,145%
Gain YTD-24.7400.783-3,159%
P/E RatioN/A31.63-
Revenue0232M-
Total Cash176M742M24%
Total Debt17.2M257M7%
FUNDAMENTALS RATINGS
ACET vs DVAX: Fundamental Ratings
ACET
DVAX
OUTLOOK RATING
1..100
6485
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9884
PRICE GROWTH RATING
1..100
9055
P/E GROWTH RATING
1..100
1596
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (36) in the Medical Distributors industry is somewhat better than the same rating for DVAX (73) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than DVAX’s over the last 12 months.

DVAX's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for ACET (100) in the Medical Distributors industry. This means that DVAX’s stock grew somewhat faster than ACET’s over the last 12 months.

DVAX's SMR Rating (84) in the Biotechnology industry is in the same range as ACET (98) in the Medical Distributors industry. This means that DVAX’s stock grew similarly to ACET’s over the last 12 months.

DVAX's Price Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for ACET (90) in the Medical Distributors industry. This means that DVAX’s stock grew somewhat faster than ACET’s over the last 12 months.

ACET's P/E Growth Rating (15) in the Medical Distributors industry is significantly better than the same rating for DVAX (96) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETDVAX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYRN17.150.44
+2.63%
Byrna Technologies
PBF19.550.29
+1.51%
PBF Energy
NBTB42.900.22
+0.52%
NBT Bancorp
DOMH3.920.02
+0.51%
Dominari Holdings
BA168.560.39
+0.23%
Boeing Company

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.50%
ARWR - ACET
42%
Loosely correlated
+3.97%
OGI - ACET
41%
Loosely correlated
-0.96%
DVAX - ACET
39%
Loosely correlated
+1.26%
CCCC - ACET
37%
Loosely correlated
+5.92%
CABA - ACET
36%
Loosely correlated
+5.98%
More